tailieunhanh - Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobinbinding therapeutics

Preclinical studies have evaluated haptoglobin (Hp) polymers from pooled human plasma as a therapeutic protein to attenuate toxic effects of cell-free hemoglobin (Hb). Proof of concept studies have demonstrated efficacy of Hp in hemolysis associated with transfusion and sickle cell anemia. | Phenotype-specific recombinant haptoglobin polymers co-expressed with C1r-like protein as optimized hemoglobinbinding therapeutics

TỪ KHÓA LIÊN QUAN